CoPPIX treatment was able to decrease alveolar-capillary membrane “leak”, alveolar monocyte and macrophage accumulation, and lung oedema, indicating that HO-1 is a key determinant of critical pathophysiologic events in this model of malaria associated lung injury. This evidence concerns the gene HMOX1 and malaria.